We are live on ! Find out more
BRA

Bender Robert & Associates Portfolio holdings

AUM $417M
1-Year Est. Return 25.02%
This Fund
S&P 500
This Quarter Est. Return
+17.29%
1 Year Est. Return
+25.02%
3 Year Est. Return
+98.12%
5 Year Est. Return
+139.29%
10 Year Est. Return
+812.75%
AUM
$362M
AUM Growth
+$39.2M
Cap. Flow
-$5.52M
Cap. Flow %
-1.52%
Top 10 Hldgs %
70.9%
Holding
56
New
1
Increased
10
Reduced
33
Closed
6

Top Buys

Rank Stock Value
1
AMD icon
Advanced Micro Devices
AMD
+$4.05M
2
LLY icon
Eli Lilly
LLY
+$3.61M
3
NOW icon
ServiceNow
NOW
+$258K
4
MSFT icon
Microsoft
MSFT
+$201K
5
FIVE icon
Five Below
FIVE
+$166K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.54M
2
AAPL icon
Apple
AAPL
+$2.34M
3
VMW
VMware, Inc
VMW
+$1.87M
4
AZN icon
AstraZeneca
AZN
+$932K
5
CTSH icon
Cognizant
CTSH
+$877K

Sector Composition

Rank Sector Weight
1 Technology 43.09%
2 Consumer Discretionary 25.56%
3 Healthcare 19.87%
4 Communication Services 9.51%
5 Utilities 0.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
26
AbbVie
ABBV
$454B
$1.83M 0.51%
13,615
-17,349
-56% -$2.54M
BMY icon
27
Bristol-Myers Squibb
BMY
$128B
$1.81M 0.5%
28,297
+410
+1% +$27.5K
PANW icon
28
Palo Alto Networks
PANW
$259B
$1.59M 0.44%
12,484
+1,410
+13% +$147K
COST icon
29
Costco
COST
$422B
$964K 0.27%
1,791
-46
-3% -$23.3K
ABT icon
30
Abbott
ABT
$182B
$888K 0.25%
8,141
-580
-7% -$61.8K
MRK icon
31
Merck
MRK
$323B
$867K 0.24%
7,516
-936
-11% -$106K
JNJ icon
32
Johnson & Johnson
JNJ
$641B
$846K 0.23%
5,109
-422
-8% -$68.1K
PAYX icon
33
Paychex
PAYX
$41.1B
$638K 0.18%
5,705
-1,130
-17% -$124K
BA icon
34
Boeing
BA
$167B
$568K 0.16%
2,689
-251
-9% -$52.1K
DE icon
35
Deere & Co
DE
$169B
$549K 0.15%
1,356
-205
-13% -$78.4K
NUE icon
36
Nucor
NUE
$56.4B
$535K 0.15%
3,260
-795
-20% -$116K
PFE icon
37
Pfizer
PFE
$141B
$520K 0.14%
14,185
-6,035
-30% -$235K
JPM icon
38
JPMorgan Chase
JPM
$947B
$519K 0.14%
3,566
-512
-13% -$70.4K
BCRX icon
39
BioCryst Pharmaceuticals
BCRX
$2.43B
$483K 0.13%
68,600
– –
URGN icon
40
UroGen Pharma
URGN
$2.02B
$359K 0.1%
34,701
– –
CAT icon
41
Caterpillar
CAT
$402B
$350K 0.1%
1,422
-195
-12% -$43.5K
ORCL icon
42
Oracle
ORCL
$345B
$285K 0.08%
2,389
– –
V icon
43
Visa
V
$689B
$266K 0.07%
1,120
– –
IDXX icon
44
Idexx Laboratories
IDXX
$43.9B
$231K 0.06%
460
-5
-1% -$2.4K
TGT icon
45
Target
TGT
$63.7B
$212K 0.06%
1,605
-450
-22% -$66.8K
DUK icon
46
Duke Energy
DUK
$100B
$206K 0.06%
2,290
-259
-10% -$24.4K
EOLS icon
47
Evolus
EOLS
$407M
$182K 0.05%
25,070
– –
PLSE icon
48
Pulse Biosciences
PLSE
$2.27B
$74.2K 0.02%
+10,325
New +$66K
SMMT icon
49
Summit Therapeutics
SMMT
$10.5B
$60.4K 0.02%
24,059
+10,000
+71% +$18.3K
CMRX
50
DELISTED
Chimerix, Inc.
CMRX
$12.8K ﹤0.01%
10,609
– –
1
2
3

Similar funds

AWCI
Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return
ACM
Alight Capital Management New York $417M AUM 98.18% 1-Year Est. Return
PA
PSI Advisors Tampa, Florida $418M AUM 15.55% 1-Year Est. Return
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
MCM
Millstreet Capital Management Boston, Massachusetts $418M AUM 80.77% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
SCP
Stevens Capital Partners Omaha, Nebraska $416M AUM 18.93% 1-Year Est. Return
VM
Venator Management Pittsburgh, Pennsylvania $416M AUM 16.01% 1-Year Est. Return

Bender Robert & Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Bender Robert & Associates held 56 positions worth $362M, up 12% from $323M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Bender Robert & Associates's Q2 2023 filing shows 1 new, 10 increased, 33 reduced and 6 closed positions. Its largest new stake was Pulse Biosciences: 10,325 shares worth $74.2K. The largest sale was AbbVie, an estimated $2.54M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bender Robert & Associates's largest Q2 2023 buy was Pulse Biosciences: 10,325 shares worth $74.2K.
  • Bender Robert & Associates added most to Advanced Micro Devices in Q2 2023, an estimated $4.05M increase.
  • Bender Robert & Associates's biggest Q2 2023 reduction was AbbVie, cutting an estimated $2.54M.
  • Bender Robert & Associates fully exited VMware, Inc in Q2 2023, selling an estimated $1.87M.
  • Bender Robert & Associates's ten largest holdings make up 71% of its $362M portfolio in Q2 2023.
  • Bender Robert & Associates opened 1 new position and closed 6 in Q2 2023.
  • Bender Robert & Associates's portfolio value rose 12% quarter-over-quarter to $362M.

Based on Bender Robert & Associates's 13F filing for Q2 2023, filed 14 Jul 2023.